An alkanecarboxylic acid derivative in the correction of immunopathological disorders in patients with multiple sclerosis associated with the activation of the human endogenous retrovirus HERV-E λ 4-1

  • I. A. Goldina Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
  • E. V. Markova Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
DOI: https://doi.org/10.25557/2310-0435.2022.03.81-82
Keywords: Neuroimmunopathology

Abstract

Conference abstract

Published
2022-10-14
How to Cite
Goldina, I. A., & Markova, E. V. (2022). An alkanecarboxylic acid derivative in the correction of immunopathological disorders in patients with multiple sclerosis associated with the activation of the human endogenous retrovirus HERV-E λ 4-1. Patogenez (Pathogenesis), 20(3), 81-82. https://doi.org/10.25557/2310-0435.2022.03.81-82
Issue
Vol. 20 No. 3 (2022): Pathogenesis
Section
Brief reports